DUBLIN, May 12, 2022--(BUSINESS WIRE)--The "Pneumatic Nebulizer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

The pneumatic nebulizer market is expected to register a 5.3% of CAGR over the forecast period. The increasing number of cases of respiratory diseases and increasing geriatric population is expected to drive the market growth.

According to the Global Burden of Disease Study, the prevalence of chronic pulmonary respiratory diseases (COPD) was found to be around 251 million and more than 90% of the COPD deaths occur in low- and middle-income countries. Hence, with the rising adoption of homecare devices by the patients it is expected to fuel the pneumatic nebulizer market growth.

Key Market Trends

Portable Pneumatic Nebulizer is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Portable pneumatic nebulizer is expected to show a robust growth owing to the rising prevalence of respiratory diseases such as asthma and COPD and increasing geriatric population. The rising adoption of portable nebulizer due to its convenience and effectiveness is expected to influence positively on the growth. According to the study of Analytica Chimica Acta, 2020, pneumatic nebulizer was used for introducing metallic ionic meta callibrant solutions and nanoparticles. Furthermore, according to the World Health Organization, currently there are approximately 339 million people in the world living with asthma and over 80% of these reside in low- and middle- income countries. Hence, these factors are expected to impact positively on the market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Pneumatic Nebulizer market owing to higher prevalence of respiratory diseases and increasing geriatric population. According to the Centre for Disease Control and Prevention, in 2017, prevalence of asthma in male was found to be approximately 6.4% and 9.3% in female in the United States. Moreover, according to the U.S. Department of Health and Human Services, around 33,401 Americans suffered from emphysema in 2018. This is expected to increase the demand for pneumatic nebulizers and thereby propelling the market growth.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Growing Burden of Respiratory Diseases

4.2.2 Increasing Demand for Home Healthcare Devices

4.2.3 Increasing Geriatric Population

4.3 Market Restraints

4.3.1 Drug Loss during Drug Delivery

4.4 Porter's Five Force Analysis


5.1 By Portability

5.1.1 Tabletop

5.1.2 Portable

5.2 By Sales Channel

5.2.1 Direct Purchase

5.2.2 Online Purchase

5.3 Geography


6.1 Company Profiles

6.1.1 Aerogen

6.1.2 Heyer Medical AG

6.1.3 GE Healthcare

6.1.4 Abbvie Inc. (Agilent Technologies)

6.1.5 Salter Labs

6.1.6 Medline Industries Inc.

6.1.7 Briggs Healthcare

6.1.8 PARI Pharma

6.1.9 Omron Healthcare


For more information about this report visit www.researchandmarkets.com/r/w7hmpp

View source version on businesswire.com: www.businesswire.com/news/home/20220512005562/en/


Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Source link